Back to School: How biopharma can reboot drug development. Access exclusive analysis here
The companies amended a 1999 deal for QTRN's Innovex subsidiary (Parsippany, N.J.) to provide a sales force and fund
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury